Clinical Laboratory Improvement Advisory Committee (CLIAC)

The Clinical Laboratory Improvement Advisory Committee shall provide scientific and technical advice and guidance to the Secretary, Department of Health and Human Services (HHS); the Assistant Secretary for Health, HHS; the Director, Centers for Disease Control and Prevention (CDC); the Commissioner, Food and Drug Administration (FDA); and the Administrator, Centers for Medicare and Medicaid Services (CMS). The advice and guidance pertain to general issues related to improvement in clinical laboratory quality and laboratory medicine and specific questions related to possible revision of the Clinical Laboratory Improvement Amendments (CLIA) standards. Examples include providing guidance on studies designed to improve safety, effectiveness, efficiency, timeliness, equity, and patient-centeredness of laboratory services; revisions to the standards under which clinical laboratories arc regulated; the impact of proposed revisions to the standards on medical and laboratory practice; and the modification of the standards and provision of non-regulatory guidelines to accommodate technological advances, such as new test methods, the electronic transmission of laboratory information, and mechanisms to improve the integration of public health and clinical laboratory practices.

Committee Information

• Charter [PDF – 386 KB]
• Roster [PDF – 57 KB]
• Clinical Laboratory Improvement Advisory Committee website

Federal Register Notices

The National Archives Office of the Federal Register provides access to all Federal Register Notices (FRNs). You can visit the Federal Register site to search for any FRN for this Federal Advisory Committee.

If you need assistance locating a specific FRN, please contact FACMT@cdc.gov.

Meeting Minutes

The meeting minutes for this committee can be found on the Clinical Laboratory Improvement Advisory Committee website.